Cryopreservation entails the usage of very low temperatures for the tissue and cell preservation. Biomedical warming and thawing devices helps in the thawing and warming of cryopreserved products. If the living cells are conserved for an extended time period, the cyropreservative chemicals can damage them. Thus, warming and thawing devices are significant to decrease the cyropreservative’s impact on the cells, assuring their viability for being uses for numerous purposes in research and healthcare.
The global biomedical warming and thawing devices market is projected to witness swift growth owing to the rising usage of cryopreservation methods for tissue and cells preservation. The strong set-up of the warming and thawing devices copes with the existing restrictions in cell preservation, harvesting, and formulation eventually resulting in fruitful therapy administrations to patients that to at an affordable price. Other key factors anticipated to fuel the market expansion are rising number of patients needing admissions within medical emergency sections, growing count of trauma incidences & road accidents, and technological improvements in healthcare services due to widespread R&D activities. Further, the growing infertility because of several reasons will drive the need for in-vitro fertilization and artificial insemination, in turn, boosting the market growth to some extent.
The global biomedical warming and thawing devices market can be segregated on the basis of end-user, sample, product, and region. The market, by product, is bifurcated into automated and manual devices. The market, by end-user, is classified into hospitals, blood banks & transfusion centers, pharmaceutical companies, and research laboratories. The market, by sample, is diversified into ovum/embryo, blood products, and semen.
Regionally, North America is projected to rule the global biomedical warming and thawing devices market during the forecast period owing to the existence of deep-rooted healthcare system, the presence huge patient pool with ailments like cancer, malignant neoplasms, organ transplants, cardiovascular diseases, & neonatal conditions, and high spending on healthcare research by the public & private healthcare sector. Europe is also projected to witness substantial expansion on account of increased need for technologically innovative biomedical warming & thawing devices and wide-ranging research undertakings on blood products in the U.K., France, and Germany. Asia Pacific will see considerable growth mainly driven by increasing alertness regarding quality-based products & cell viability for study, fortifying of healthcare infrastructure, and rising usage of biomedical devices.
Major players actively participating in the global biomedical warming and thawing devices market consists of BioCision, Helmer Scientific, Sartorius AG, General Electric Company, Boekel Scientific, Sarstedt AG & Co. KG, Cardinal Health, CytoTherm, Thermo Fisher Scientific, and Barkey, among others.
Recent development: The U.S. FDA had given green signal to the plasma thawing device, ZipThaw, of FreMon Scientific, in July 2020. ZipThaw is a portable and dry plasma thawing system. This planned move was intended to fortify their product portfolio and gain a competitive edge in the market.
